Out of a 100 patients diagnosed with IgA and IgG multiple myeloma, five patients aged 64, 64, 63, 61, and 58 years, respectively, received induction therapy with four cycles of bortezomib, thalidomide, and dexamethasone or four cycles of bortezomib, cyclophosphamide, and dexamethasone allowing a complete remission in all cases. Here, CD79A is linked to AL amyloidosis.